ISTH/LinkedIn
Aug 14, 2026, 06:26
Delivering Gene Therapy in Hemophilia – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared on LinkedIn:
“Delivering gene therapy in hemophilia isn’t just a clinical decision, it’s an operational one. From referral pathways to long-term monitoring, successful implementation requires coordination across teams, systems, and care models.
Our new resource builder helps you not only navigate referral, preparation, and administration workflows, but grants you access to tools tailored to your region and practice setting.
Support your team in managing the complexities of gene therapy by building a personalized set of implementation resources and taking the next step toward integrating gene therapy into practice!”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering